Association of Metformin use with risk of dementia in patients with type 2 diabetes: A systematic review and meta‐analysis

Documenti analoghi

• Real‐world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta‐analysis
  di: Qin Yang, et al.
  Pubblicazione: (2024)
• Antidiabetic agents and dementia risk in type 2 diabetes: A systematic review and network meta‐analysis
  di: Sayaka Kato, et al.
  Pubblicazione: (2025)
• Glycated haemoglobin variability and risk of renal function decline in type 2 diabetes mellitus: An updated systematic review and meta‐analysis
  di: Shihan Wang, et al.
  Pubblicazione: (2024)
• Metformin lowers risk of hearing loss and mortality in type 2 diabetes
  di: Chun‐Chih Huang, et al.
  Pubblicazione: (2024)
• The effect of GLP ‐1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta‐analysis
  di: Yifan Ren, et al.
  Pubblicazione: (2025)